Nevro Corp (NVRO)
4.05
+0.08
(+2.02%)
USD |
NYSE |
Dec 26, 16:00
4.055
0.00 (0.00%)
Pre-Market: 20:00
Nevro Research and Development Expense (Quarterly): 10.58M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Inspire Medical Systems Inc | 26.08M |
Inari Medical Inc | 29.43M |
Stereotaxis Inc | 2.454M |
Electromed Inc | 0.166M |
Myomo Inc | 1.249M |